Benitec Biopharma Inc.

BNTC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
UPLOAD Feb 6, 2026
S-3 Jan 30, 2026 S-3
SCHEDULE 13G/A Jan 29, 2026
4 Jan 26, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Dec 29, 2025
4 Dec 22, 2025
SCHEDULE 13G/A Dec 8, 2025
SCHEDULE 13G Dec 3, 2025
4 Dec 3, 2025 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Dec 3, 2025 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Dec 3, 2025 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Dec 3, 2025 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Dec 3, 2025 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
8-K Dec 2, 2025 8-K
4 Nov 20, 2025 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Nov 20, 2025 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Nov 20, 2025 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
8-K Nov 14, 2025 8-K
10-Q Nov 14, 2025 10-Q
DEFA14A Nov 12, 2025 DEFA14A
SCHEDULE 13D/A Nov 10, 2025
4 Nov 10, 2025
4 Nov 7, 2025 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
3 Nov 7, 2025 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
8-K Nov 7, 2025 8-K
← Newer Page 2 of 14 · 334 filings Older →